Search Results - "Vranova, H"

Cerebrospinal fluid levels of chromogranin A and phosphorylated neurofilament heavy chain are elevated in amyotrophic lateral sclerosis by Kaiserova, M., Grambalova, Z., Otruba, P., Stejskal, D., Prikrylova Vranova, H., Mares, J., Mensikova, K., Kanovsky, P.

“…Background Various cerebrospinal fluid (CSF) biomarkers are being studied to improve the sensitivity and specificity of the diagnostic methods for amyotrophic…”
Get full text

UHPLC-MS/MS quantitative profiling of tryptophane-related neuroactive substances in cerebrospinal fluid in Parkinson's disease patients by Kanovsky, P, Prikrylova Vranova, H, Mares, J, Mensikova, K, Henykova, E, Amakorova, P, Strnad, M

Get full text

High sensitivity biosensor measurement based on synchronous detection by Krejci, J., Ondruch, V., Maly, J., Stofik, M., Krejcova, D., Vranova, H.

“…The principle of synchronous detection (SD) has been applied to biosensor measurement. SD principle achieves significant increases in the signal to noise…”
Get full text

Effect of levodopa and entacapone treatment on plasma homocysteine levels in Parkinson's disease patients by Nevrly, M, Kanovsky, P, Vranova, H, Langova, K, Hlustik, P

Get full text

Cerebrospinal fluid inflammatory markers in patients with multiple sclerosis: a pilot study by MatejAeikova, Z, Mares, J, Prikrylova Vranova, H, Klosova, J, Sladkova, V, Dolakova, J, Zapletalova, J, Kaovsky, P

“…Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system. Autoimmune inflammation is common in the early stages of MS…”
Get full text

New laboratory markers in diagnosis of alzheimer dementia by Mareš, J., Kanovsky, P., Herzig, R., Stejskal, D., Vavrouskova, J., Hlustik, P., Vranova, H., Burval, S., Zapletalova, J., Pidrman, V., Obereigneru, R., Suchy, A., Vesely, J., Podivinsky, J., Urbanek, K.

“…Objectives: The aim of our work was to assess the role of tau protein, beta amyloid and cystatin C in diagnosis of Alzheimer dementia (AD) and other…”
Get full text

The assessment of beta amyloid, tau protein and cystatin C in the cerebrospinal fluid: laboratory markers of neurodegenerative diseases by Mares, Jan, Kanovsky, P., Herzig, R., Stejskal, D., Vavrouskova, J., Hlustik, P., Vranova, H., Burval, S., Zapletalova, J., Pidrman, V., Obereigneru, R., Suchy, A., Vesely, J., Podivinsky, J., Urbanek, K.

“…To assess the role of tau protein, beta-amyloid (1–42) and cystatin C in the diagnostics of Alzheimer dementia (AD) and other neurodegenerative diseases (ND)…”
Get full text

FP43-TH-01 The assessment of beta amyloid, tau protein and cystatin C in the cerebrospinal fluid – laboratory markers of neurodegenerative diseases by Mares, J, Herzig, R, Stejskal, D, Vavrouskova, J, Hlustik, P, Vranova, H, Burval, S, Zapletalova, J, Pidrman, V, Obereingeru, R, Suchy, A, Vesely, J, Podivinsky, J, Kanovsky, P

Get full text

2.301 Is the Braak's staging really useful? A correlation analysis of neurodegeneration markers in cerebrospinal fluid and motor impairment in Parkinson disease by Vranova, H, Kanovsky, P, Nestrasil, I, Mares, J, Nevrly, M, Stejskal, D

Get full text

1.161 Plasma homocysteine concentration and peripheral neuropathy in Parkinson's disease patients: A pilot study by Nevrly, M, Vranova, H, Chovancova, Z, Nestrasil, I, Otruba, P, Dufek, J, Kanovsky, P

Get full text

Sensorimotor plasticity due to botulinum-toxin treatment of leg spasticity in multiple sclerosis: A functional MRI study by Hlustik, P., Vyslouzilova, J., Hok, P., Sladkova, V., Prikrylova-Vranova, H., Mares, J., Otruba, P., Kanovsky, P.

Get full text

P3.147 Neurodegenerative markers in CSF in patients suffering from Parkinson's disease by Vranová, H, Nevrlý, M, Mareš, J, Stejskal, D, Kañovský, P

Get full text

From Parkinson's Disease to Alzheimer Disease (P06.080) by Prikrylova Vranova, H., Nevrly, M., Hlustik, P., Mares, J., Obereigneru, R., Kanovsky, P.

“…Abstract only…”
Get full text